| 000 | 01173 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250518005103.0 | ||
| 264 | 0 | _c20190513 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1096-1186 | ||
| 024 | 7 |
_a10.1016/j.phrs.2018.11.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMotaghi, Ehsan | |
| 245 | 0 | 0 |
_aEtrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: A systematic review and indirect comparison. _h[electronic resource] |
| 260 |
_bPharmacological research _c01 2019 |
||
| 300 |
_a120-125 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfliximab _xtherapeutic use |
| 700 | 1 | _aGhasemi-Pirbaluti, Masoumeh | |
| 700 | 1 | _aZabihi, Mohsen | |
| 773 | 0 |
_tPharmacological research _gvol. 139 _gp. 120-125 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phrs.2018.11.003 _zAvailable from publisher's website |
| 999 |
_c29012310 _d29012310 |
||